Repligen Corp. [RGEN] stock prices are down -2.41% to $161.67 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The RGEN shares have gain 14.83% over the last week, with a monthly amount glided 33.87%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Repligen Corp. [NASDAQ: RGEN] stock has seen the most recent analyst activity on June 26, 2024, when Deutsche Bank upgraded its rating to a Buy and also revised its price target to $155 from $180. On December 04, 2023, downgrade downgraded it’s rating to Hold. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $185 on July 20, 2023. The Benchmark Company started tracking with a Buy rating for this stock on March 28, 2023, and assigned it a price target of $230. In a note dated December 14, 2022, Deutsche Bank initiated an Hold rating and provided a target price of $180 on this stock.
The stock price of Repligen Corp. [RGEN] has been fluctuating between $110.45 and $211.13 over the past year. Currently, Wall Street analysts expect the stock to reach $189.5 within the next 12 months. Repligen Corp. [NASDAQ: RGEN] shares were valued at $161.67 at the most recent close of the market. An investor can expect a potential return of 17.21% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp. [NASDAQ:RGEN] reported sales of 602.35M for trailing twelve months, representing a drop of -3.20%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is 0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 154.98 points at the first support level, and at 148.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 165.54, and for the 2nd resistance point, it is at 169.40.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp. [NASDAQ:RGEN]’s Current Ratio is 6.65. On the other hand, the Quick Ratio is 5.56, and the Cash Ratio is 4.64. Considering the valuation of this stock, the price to sales ratio is 15.03, the price to book ratio is 4.55.
Transactions by insiders
Recent insider trading involved Ralf Kuriyel, Senior Vice President, that happened on Aug 02 ’24 when 7148.0 shares were purchased. Senior Vice President, Ralf Kuriyel completed a deal on Aug 01 ’24 to buy 4465.0 shares. Meanwhile, Senior Vice President Christine Gebski bought 2160.0 shares on Aug 01 ’24.
